Search Results
Employee's Frustration Led to Drug Development for Myasthenia Gravis
Drug Development Roundtable
Overview of Myasthenia Gravis
UCB Announces Phase 3 Results for Zilucoplan and Rozanolixizumab in Generalized Myasthenia Gravis (g
Introduction to Ra Pharma & the Potential of Zilucoplan for the Treatment of IMNM
Developing Treatment for Hereditary Neuromuscular Disease
RI patients receiving controversial Alzheimer’s drug amid coverage questions
Untangling the ALS X Files
How To "Do" Business Development For Your Own Clinical Research Career or Company
Neurologic and Psychiatric Effects of SARS-CoV-2 Meeting: Day 2
MDA Engage IBM Virtual Symposium 4 20
Clifton Leaf/Brian Caveney at the 17th Annual Personalized Medicine Conference
